We are live on ! Find out more
HJGA

Hardman Johnston Global Advisors Portfolio holdings

AUM $2.1B
1-Year Est. Return 41.89%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+41.89%
3 Year Est. Return
+117.99%
5 Year Est. Return
+176.75%
10 Year Est. Return
+717.76%
AUM
$2.35B
AUM Growth
-$9.47M
Cap. Flow
-$28M
Cap. Flow %
-1.19%
Top 10 Hldgs %
62.15%
Holding
73
New
1
Increased
12
Reduced
43
Closed
1

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$70.4M
2
CELG
Celgene Corp
CELG
+$27.9M
3
ASML icon
ASML
ASML
+$14.8M
4
ADBE icon
Adobe
ADBE
+$14M
5
AAPL icon
Apple
AAPL
+$13.8M

Sector Composition

Rank Sector Weight
1 Technology 27.52%
2 Consumer Discretionary 22.1%
3 Healthcare 20.07%
4 Financials 15.53%
5 Communication Services 3.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHG icon
26
Philips
PHG
$25.8B
$25.2M 1.07%
867,371
-7,919
-0.9% -$235K
JNJ icon
27
Johnson & Johnson
JNJ
$617B
$24.7M 1.05%
192,489
-2,885
-1% -$390K
EOG icon
28
EOG Resources
EOG
$77.5B
$22.8M 0.97%
216,945
-2,030
-0.9% -$219K
AAPL icon
29
Apple
AAPL
$4.9T
$22.3M 0.95%
531,976
-319,780
-38% -$13.8M
JPM icon
30
JPMorgan Chase
JPM
$933B
$20.9M 0.89%
189,700
-5,570
-3% -$631K
FMC icon
31
FMC
FMC
$1.48B
$20.3M 0.86%
306,094
-3,171
-1% -$236K
PTC icon
32
PTC
PTC
$15.7B
$20.1M 0.86%
257,830
+135,090
+110% +$9.85M
AMZN icon
33
Amazon
AMZN
$2.53T
$19.7M 0.84%
272,800
-94,700
-26% -$6.77M
DGX icon
34
Quest Diagnostics
DGX
$25.9B
$19.6M 0.84%
195,822
-2,790
-1% -$286K
ALB icon
35
Albemarle
ALB
$13.9B
$19.1M 0.81%
205,902
-108,170
-34% -$11.9M
GOOG icon
36
Alphabet (Google) Class C
GOOG
$4.08T
$18.1M 0.77%
350,160
-51,040
-13% -$2.82M
CERN
37
DELISTED
Cerner Corp
CERN
$17.8M 0.76%
306,106
-2,090
-0.7% -$136K
CELG
38
DELISTED
Celgene Corp
CELG
$13.1M 0.56%
147,070
-290,800
-66% -$27.9M
OXY icon
39
Occidental Petroleum
OXY
$55.6B
$13M 0.55%
199,950
-4,620
-2% -$323K
SHPG
40
DELISTED
Shire pic
SHPG
$11.9M 0.51%
79,504
-95,118
-54% -$13.1M
GE icon
41
GE Aerospace
GE
$368B
$11.4M 0.48%
175,936
+1,647
+0.9% +$122K
SBUX icon
42
Starbucks
SBUX
$121B
$10.8M 0.46%
186,060
+19,390
+12% +$1.12M
META icon
43
Meta Platforms (Facebook)
META
$1.37T
$9.63M 0.41%
60,290
-51,120
-46% -$9.18M
NVRO
44
DELISTED
NEVRO CORP.
NVRO
$8.72M 0.37%
100,590
+340
+0.3% +$27.5K
EPD icon
45
Enterprise Products Partners
EPD
$82.5B
$5.58M 0.24%
228,026
JAZZ icon
46
Jazz Pharmaceuticals
JAZZ
$16.2B
$5.5M 0.23%
36,460
-1,340
-4% -$197K
ABBV icon
47
AbbVie
ABBV
$455B
$4.69M 0.2%
49,508
-100
-0.2% -$11K
ABT icon
48
Abbott
ABT
$183B
$2.97M 0.13%
49,558
FMS icon
49
Fresenius Medical Care
FMS
$13.8B
$2.84M 0.12%
55,640
-61
-0.1% -$3.25K
XOM icon
50
ExxonMobil
XOM
$651B
$2.48M 0.11%
33,283
+545
+2% +$43.6K

Similar funds

Hardman Johnston Global Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Hardman Johnston Global Advisors held 73 positions worth $2.35B, down 0.4% from $2.36B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 2.7%. Hardman Johnston Global Advisors opened 1 new position and exited 1, leaving the 73-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Hardman Johnston Global Advisors's largest Q1 2018 buy was Vertex Pharmaceuticals: 188,900 shares worth $30.8M.
  • Hardman Johnston Global Advisors added most to Melco Resorts & Entertainment in Q1 2018, an estimated $87.5M increase.
  • Hardman Johnston Global Advisors's biggest Q1 2018 reduction was Celgene Corp, cutting an estimated $27.9M.
  • Hardman Johnston Global Advisors fully exited NXP Semiconductors in Q1 2018, selling an estimated $70.4M.
  • Hardman Johnston Global Advisors's ten largest holdings make up 62% of its $2.35B portfolio in Q1 2018.
  • Hardman Johnston Global Advisors opened 1 new position and closed 1 in Q1 2018.
  • Hardman Johnston Global Advisors's portfolio value fell 0.4% quarter-over-quarter to $2.35B.

Based on Hardman Johnston Global Advisors's 13F filing for Q1 2018, filed 30 Apr 2018.